Oncovin and Lipitor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Oncovin (vincristine sulfate) and Lipitor (atorvastatin calcium). Common drug interactions include pyrexia among females and clostridium difficile colitis among males.

The phase IV clinical study analyzes what interactions people have when they take Oncovin and Lipitor. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Oncovin?

Oncovin has active ingredients of vincristine sulfate. eHealthMe is studying from 6,667 Oncovin users. Check the latest studies of Oncovin.

What is Lipitor?

Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,047 Lipitor users. Check the latest studies of Lipitor.

On Jul, 14, 2026

23 people who take Oncovin and Lipitor together, and have interactions are studied.

What are the common drug interactions of Oncovin and Lipitor, by gender? *:

female:

Pyrexia (fever)
Rash macular (small, flat red spots)
Renal failure (kidney dysfunction)
Urine output decreased
White blood cell count increased
Erythema (redness of the skin)
Palpitations (feelings or sensations that your heart is pounding or racing)
Anaemia (lack of blood)
Asthenia (weakness)
Cervix carcinoma (cancer of cervix)

male:

Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Intervertebral disc degeneration (spinal disc degeneration)
Diastolic dysfunction
Dyspnoea (difficult or laboured respiration)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Hyperlipidaemia (presence of excess lipids in the blood)
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Inappropriate antidiuretic hormone secretion
Intervertebral discitis (infection in the intervertebral disc space)

What are the common drug interactions of Oncovin and Lipitor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Chest pain
Nausea (feeling of having an urge to vomit)
Oropharyngeal pain
Pain in extremity
Pain in jaw
Weight decreased

60+:

Pleural effusion (water on the lungs)
Dyspnoea (difficult or laboured respiration)
Blood urea increased
Gamma-glutamyltransferase increased
Haemoglobin decreased
Interstitial lung disease
Intervertebral disc degeneration (spinal disc degeneration)
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Lymphocyte count decreased
Lymphocyte stimulation test positive

What are the existing conditions these people have? *

High Blood Pressure: 6 people, 26.09%
Malignant Melanoma (skin cancer rises from melancytes): 5 people, 21.74%
Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 21.74%
Fever: 5 people, 21.74%
Burkitt Lymphoma (cancer of the lymphatic system): 5 people, 21.74%
Lymphoma (cancer that begins in immune system cells): 3 people, 13.04%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 8.70%
Muscle Spasms (muscle contraction): 2 people, 8.70%
Lymphocytosis (an increase in the number or proportion of lymphocytes in the blood): 2 people, 8.70%
Adult T-Cell Lymphoma/leukaemia (cancer of the immune system's own t-cells): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Oncovin and Lipitor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously